Related Experiment Video
Updated: Jan 17, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Charcot-Marie-Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death
Mariana Joaquim1,2,3, Maria-Bianca Bulimaga1,2,3,4, Marie A Mohn1,2
1Institute for Genetics, University of Cologne, 50674 Cologne, Germany.
Abstract:
The neuropathy Charcot-Marie-Tooth (CMT) is an incurable disease with a lack of genotype-phenotype correlation. Variants of the mitochondrial protein mitofusin 2 (MFN2), a large GTPase that mediates mitochondrial fusion, are responsible for the subtype CMT type 2A (CMT2A). Interestingly, beyond membrane remodelling, additional roles of MFN2 have been identified, expanding the possibilities to explore its involvement in disease. Here, we investigated how cellular functions of MFN2 are associated with variants present in individuals with CMT2A. Using human cellular models, we observed that cells expressing CMT2A variants display increased endoplasmic reticulum (ER) stress and apoptotic cell death. Increased cleavage of PARP1, caspase 9, caspase 7 and caspase 3, alongside BAX translocation to mitochondria, pointed towards effects on intrinsic apoptosis. Moreover, although disruption of fusion and fission dynamics per se did not correlate with cell death markers, expression of MFN1 or MFN2 alleviated the apoptosis markers of CMT2A variant cell lines. In sum, our results highlight excessive cell death by intrinsic apoptosis as a potential target in CMT2A disease.
Insights
Charcot-Marie-Tooth type 2A (CMT2A) involves variants in mitofusin 2 (MFN2). Research shows these variants increase endoplasmic reticulum stress and intrinsic apoptosis, suggesting cell death as a therapeutic target for CMT2A.
Area of Science:
- Mitochondrial biology
- Neurodegenerative diseases
- Cellular stress responses
Background:
- Charcot-Marie-Tooth (CMT) is an incurable neuropathy with limited genotype-phenotype correlation.
- Mitofusin 2 (MFN2) variants cause CMT type 2A (CMT2A), a subtype affecting mitochondrial fusion.
- MFN2 has roles beyond membrane dynamics, suggesting broader disease involvement.
Purpose of the Study:
- To investigate the association between MFN2 variants and cellular dysfunction in CMT2A.
- To explore the impact of CMT2A-associated MFN2 variants on cellular processes.
- To identify potential therapeutic targets for CMT2A.
Main Methods:
- Utilized human cellular models expressing CMT2A-associated MFN2 variants.
- Assessed endoplasmic reticulum (ER) stress and apoptotic cell death markers.
- Analyzed caspase cleavage, PARP1 cleavage, and BAX translocation to mitochondria.
Main Results:
- Cells with CMT2A MFN2 variants exhibited increased ER stress and apoptotic cell death.
- Evidence pointed to intrinsic apoptosis pathway activation, including caspase cascade and BAX translocation.
- Disruption of mitochondrial dynamics alone did not correlate with cell death, but MFN1/MFN2 expression reduced apoptosis markers.
Conclusions:
- Excessive intrinsic apoptosis is a key feature of CMT2A.
- MFN2 variants in CMT2A contribute to cellular dysfunction via ER stress and apoptosis.
- Targeting intrinsic apoptosis pathways may offer a therapeutic strategy for CMT2A.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway
Apoptosis

